Amvalor
USPTO PatentsView assignee record - 8 granted patents across 16 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B23B (TURNING; Boring).
The verdict
According to USPTO PatentsView, Amvalor ranks #30,823 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 16 technology areas.
- #30,823
- of 49,997 US assignees by volume
- Top 50%
- by Innovation Score (35.2/100)
- 11.4
- avg claims per patent
- +33%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R30823 · Foreign Corporation #30,823 · 8 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-UP · BOOK-FULL
- GRANTS-MICRO 8 grants
- MID-PACK #30,823/49,997
- PHOTO-FINISH Amira Pharmaceuticals
- CPC-FOCUS B23B · 16 areas
- INNOV-THIN 35.2/100
- CLAIMS-PAR 11.4 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-UP +33% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Amira Pharmaceuticals, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Amvalor’s 35.2 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Amvalor
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Amvalor · this assignee
Amvalor · this assignee
35 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Amvalor's Innovation Score is 35.2/100 (top 50% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Amvalor?
Each dot is one of Amvalor’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Amvalor’s own 11.4 claims/patent is ABOVE the 10.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Amvalor's grants concentrate
Amvalor is a focused PatentsView assignee: 16 CPC subclasses with 50% of grants classified under B23B (TURNING; Boring). Peak complete grant year is 2022 (3 grants) versus a trough of 1 in 2018. By volume, Amvalor sits between Amira Pharmaceuticals, Inc. and Angle North America, Inc..
Amvalor's three-year grant acceleration
Amvalor shows 3 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Amvalor's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Amira Pharmaceuti…
Amira Pharmaceuticals, Inc.
8 patents
- Amita
Amita Technologies Inc.
8 patents
- Ampac
Ampac Limited
8 patents
- Ampsource Biophar…
Ampsource Biopharma Shanghai Inc.
8 patents
- Anaergia B V
Anaergia B.V.
8 patents
- Analogix Internat…
Analogix International LLC
8 patents
- Angelcare Feeding…
Angelcare Feeding USA, LLC
8 patents
- Angle North Ameri…
Angle North America, Inc.
8 patents
- Amvalor ◀
Amvalor
8 patents
What this shows Amvalor holds 8 patents at rank #30,772, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Amvalor
By rank, the assignees closest to #30,772 in granted patent volume.
- Amira Pharmaceuticals, Inc. #30,768 · 8 patents
- Amita Technologies Inc. #30,769 · 8 patents
- Ampac Limited #30,770 · 8 patents
- Ampsource Biopharma Shanghai Inc. #30,771 · 8 patents
- Anaergia B.V. #30,773 · 8 patents
- Analogix International LLC #30,774 · 8 patents
- Angelcare Feeding USA, LLC #30,775 · 8 patents
- Angle North America, Inc. #30,776 · 8 patents
Leaders in B23B (Turning)
Other assignees with the most granted patents in Amvalor's primary technology class.
Amvalor's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
35 Top 50% higher than 50% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 1 | 12.5% |
| 2019 | 2 | 25.0% |
| 2020 | 1 | 12.5% |
| 2022 | 3 | 37.5% |
| 2025partial year | 1 | 12.5% |
Which technologies does Amvalor patent most?
Top 15 of 16 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Amvalor's patent record in context - here's where to go next.
- Amvalor's lead technology class is B23B (TURNING; Boring), 50% of its portfolio - see every assignee active in that class. Explore B23B
- Ranked #30,823 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Amvalor against Amira Pharmaceuticals, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 35.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.